Synvista Therapeutics, Inc. (SYNI)

Synvista Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Sep 30, 2008	Dec 31, 2007	Dec 31, 2006	Dec 31, 2005	Dec 31, 2004	Dec 31, 2003
Revenue	0.05	0.05	0.06	0.1	0.15	-
Revenue Growth (YoY)	-51.63%	-17.73%	-37.93%	-34.13%	-	-
Gross Profit	0.05	0.05	0.06	0.1	0.15	-
Selling, General & Admin	4.6	3.93	4.92	4.33	4.53	5.05
Research & Development	6.48	6.04	1.63	9.07	10.15	9.93
Operating Expenses	11.08	9.96	6.55	13.4	14.68	14.98
Operating Income	-11.03	-9.91	-6.49	-13.3	-14.53	-14.98
Interest Expense	-0.01	-6.64	-	-	-	-
Interest & Investment Income	0.46	0.46	0.19	0.36	0.18	0.18
Other Non Operating Income (Expenses)	0.01	-	-	-	-	-
EBT Excluding Unusual Items	-10.56	-16.09	-6.3	-12.94	-14.34	-14.8
Pretax Income	-10.96	-16.09	-17.68	-12.94	-14.34	-14.8
Income Tax Expense	-	-	-	-0.33	-0.39	-0.34
Net Income	-10.96	-16.09	-17.68	-12.61	-13.96	-14.45
Preferred Dividends & Other Adjustments	8.84	3.85	2.65	4.49	4.14	3.79
Net Income to Common	-19.8	-19.95	-20.33	-17.1	-18.09	-18.24
Shares Outstanding (Basic)	3	3	2	1	1	1
Shares Outstanding (Diluted)	3	3	2	1	1	1
Shares Change (YoY)	-0.08%	41.43%	58.63%	29.97%	22.55%	13.83%
EPS (Basic)	-7.66	-7.71	-11.12	-14.83	-20.40	-25.21
EPS (Diluted)	-7.66	-7.71	-11.12	-14.83	-20.40	-25.21
Free Cash Flow	-9.34	-7.96	-7.44	-14.05	-13.19	-15.99
Free Cash Flow Per Share	-3.61	-3.08	-4.07	-12.18	-14.87	-22.09
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	-
Operating Margin	-20147.39%	-19410.73%	-10454.21%	-13299.47%	-9568.79%	-
Profit Margin	-36186.46%	-39060.55%	-32757.76%	-17100.79%	-11917.84%	-
Free Cash Flow Margin	-17066.99%	-15595.12%	-11983.88%	-14045.90%	-8688.55%	-
EBITDA	-11.01	-9.9	-6.44	-13.23	-14.45	-14.47
D&A For EBITDA	0.01	0.01	0.05	0.07	0.07	0.5
EBIT	-11.03	-9.91	-6.49	-13.3	-14.53	-14.98
Revenue as Reported	-	-	-	-	-	0.18

Source: S&P Global Market Intelligence. Standard template. Financial Sources.